197 related articles for article (PubMed ID: 10799716)
21. Sphingolipid signaling in epidermal homeostasis. Current knowledge and new therapeutic approaches in dermatology.
Geilen CC; Barz S; Bektas M
Skin Pharmacol Appl Skin Physiol; 2001; 14(5):261-71. PubMed ID: 11586067
[TBL] [Abstract][Full Text] [Related]
22. Multifaceted roles of sphingosine-1-phosphate: how does this bioactive sphingolipid fit with acute neurological injury?
Singh IN; Hall ED
J Neurosci Res; 2008 May; 86(7):1419-33. PubMed ID: 18058948
[TBL] [Abstract][Full Text] [Related]
23. Nitric oxide and sphingolipids: mechanisms of interaction and role in cellular pathophysiology.
Perrotta C; De Palma C; Clementi E
Biol Chem; 2008 Nov; 389(11):1391-7. PubMed ID: 18783333
[TBL] [Abstract][Full Text] [Related]
24. Sphingolipid metabolism: roles in signal transduction and disruption by fumonisins.
Merrill AH; Sullards MC; Wang E; Voss KA; Riley RT
Environ Health Perspect; 2001 May; 109 Suppl 2(Suppl 2):283-9. PubMed ID: 11359697
[TBL] [Abstract][Full Text] [Related]
25. Gene expression of sphingolipid metabolism pathways is altered in hidradenitis suppurativa.
Dany M; Elston D
J Am Acad Dermatol; 2017 Aug; 77(2):268-273.e6. PubMed ID: 28551069
[TBL] [Abstract][Full Text] [Related]
26. Sphingolipids and Atherosclerosis: The Dual Role of Ceramide and Sphingosine-1-Phosphate.
Piccoli M; Cirillo F; Ghiroldi A; Rota P; Coviello S; Tarantino A; La Rocca P; Lavota I; Creo P; Signorelli P; Pappone C; Anastasia L
Antioxidants (Basel); 2023 Jan; 12(1):. PubMed ID: 36671005
[TBL] [Abstract][Full Text] [Related]
27. Sphingolipid regulation of female gonadal cell apoptosis.
Morita Y; Tilly JL
Ann N Y Acad Sci; 2000 Apr; 905():209-20. PubMed ID: 10818455
[TBL] [Abstract][Full Text] [Related]
28. Sphingolipid metabolism and its relationship with cardiovascular, renal and metabolic diseases.
Hernández-Bello F; Franco M; Pérez-Méndez Ó; Donis-Maturano L; Zarco-Olvera G; Bautista-Pérez R
Arch Cardiol Mex; 2023; 93(1):88-95. PubMed ID: 36757794
[TBL] [Abstract][Full Text] [Related]
29. Sphingosine signaling and atherogenesis.
Xu CB; Hansen-Schwartz J; Edvinsson L
Acta Pharmacol Sin; 2004 Jul; 25(7):849-54. PubMed ID: 15210056
[TBL] [Abstract][Full Text] [Related]
30. Dual signaling evoked by oxidized LDLs in vascular cells.
Nègre-Salvayre A; Augé N; Camaré C; Bacchetti T; Ferretti G; Salvayre R
Free Radic Biol Med; 2017 May; 106():118-133. PubMed ID: 28189852
[TBL] [Abstract][Full Text] [Related]
31. Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology.
Tan-Chen S; Guitton J; Bourron O; Le Stunff H; Hajduch E
Front Endocrinol (Lausanne); 2020; 11():491. PubMed ID: 32849282
[TBL] [Abstract][Full Text] [Related]
32. Sphingolipid metabolites in neural signalling and function.
Colombaioni L; Garcia-Gil M
Brain Res Brain Res Rev; 2004 Nov; 46(3):328-55. PubMed ID: 15571774
[TBL] [Abstract][Full Text] [Related]
33. Sphingolipids in multiple sclerosis.
Jana A; Pahan K
Neuromolecular Med; 2010 Dec; 12(4):351-61. PubMed ID: 20607622
[TBL] [Abstract][Full Text] [Related]
34. Sphingolipids--the enigmatic lipid class: biochemistry, physiology, and pathophysiology.
Merrill AH; Schmelz EM; Dillehay DL; Spiegel S; Shayman JA; Schroeder JJ; Riley RT; Voss KA; Wang E
Toxicol Appl Pharmacol; 1997 Jan; 142(1):208-25. PubMed ID: 9007051
[TBL] [Abstract][Full Text] [Related]
35. Sphingolipid-mediated calcium signaling and its pathological effects.
Pulli I; Asghar MY; Kemppainen K; Törnquist K
Biochim Biophys Acta Mol Cell Res; 2018 Nov; 1865(11 Pt B):1668-1677. PubMed ID: 29704533
[TBL] [Abstract][Full Text] [Related]
36. Inhibitors of the sphingomyelin cycle: Sphingomyelin synthases and sphingomyelinases.
Adada M; Luberto C; Canals D
Chem Phys Lipids; 2016 May; 197():45-59. PubMed ID: 26200918
[TBL] [Abstract][Full Text] [Related]
37. The differential regulation of cyclic AMP by sphingomyelin-derived lipids and the modulation of sphingolipid-stimulated extracellular signal regulated kinase-2 in airway smooth muscle.
Pyne S; Pyne NJ
Biochem J; 1996 May; 315 ( Pt 3)(Pt 3):917-23. PubMed ID: 8645177
[TBL] [Abstract][Full Text] [Related]
38. Sphingolipid mediators in cardiovascular cell biology and pathology.
Levade T; Augé N; Veldman RJ; Cuvillier O; Nègre-Salvayre A; Salvayre R
Circ Res; 2001 Nov; 89(11):957-68. PubMed ID: 11717151
[TBL] [Abstract][Full Text] [Related]
39. The sphingolipid salvage pathway in ceramide metabolism and signaling.
Kitatani K; Idkowiak-Baldys J; Hannun YA
Cell Signal; 2008 Jun; 20(6):1010-8. PubMed ID: 18191382
[TBL] [Abstract][Full Text] [Related]
40. Regulation of sphingosine kinase and sphingolipid signaling.
Pitson SM
Trends Biochem Sci; 2011 Feb; 36(2):97-107. PubMed ID: 20870412
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
